Buscar
Mostrando ítems 1-10 de 91
Sexual function, menopause and hormone replacement therapy (HRT)
(Elsevier, 2004)
Objective: To assess the prevalence of female sexual dysfunction in premenopausal and postmenopausal women with and
without hormone replacement therapy (HRT). To determine the relationship between menopause and sexual ...
Age at menopause in Latin America
(2006)
OBJECTIVE: To assess the age at menopause (AM) in Latin America urban areas. DESIGN: A total of 17,150 healthy women, aged 40 to 59 years, accompanying patients to healthcare centers in 47 cities of 15 Latin American ...
Decision-making for the treatment of climacteric symptoms using the menopause rating scale
(Elsevier, 2018-05)
Objective: The Menopause Rating Scale (MRS) is one of the most frequently used instruments to evaluate menopausal symptoms; however, no cut-off score is given that would indicate the need for treatment. Our goal was to ...
Factores predictores de conductas promotoras de salud en mujeres peri- post-menopáusicas de Cali, Colombia.
(2012-12-12)
Introducción: La mujer ha elevado su esperanza de vida en las últimas décadas, esto coincide con su ciclo vital de aparición
de la peri- post-menopausia, este período presenta complejos cambios en su dimensión ...
Los riesgos de no usar terapia hormonal de la menopausia: deterioro de la calidad de vida
(Sociedad Médica Santiago, 2017)
Menopause is associated with several symptoms which, if they reach certain
intensity, can severely impair the quality of life. Overall, 90.9% of Latin American
women will have at least one climacteric symptom and in 25%, ...
Menopause or climacteric, just a semantic discussion or has it clinical implications?
(Informa Healthcare, 2014)
Climacteric and menopause are two terms that are indistinctly used to name clinical expected events related to the decline in ovarian function. Thus, in the literature and in clinical settings we read and hear 'menopausal ...
Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction
(2008)
Aim. To evaluate with validated instruments changes in quality of life and sexuality in women receiving hormonal replacement therapy (AHT). Design. Randomised, double-blind, double-dummy study with two parallel treatment ...
Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
(Taylor & Francis, 2016)
Objective: To evaluate whether menopausal status and symptoms among female gynecologists would influence their clinical behavior related to menopausal hormone therapy (MHT).Methods: Female gynecologists of 11 Latin American ...
Assessment of quality of life using the menopause rating scale in women aged 40 to 59 years Evaluación de la calidad de vida en mujeres de 40 a 59 años mediante la escala MRS (menopause rating scale)
(2008)
Background: Climacteric symptoms have a direct relationship with biological and sociocultural factors and significantly impair the quality of life of women. Aim: To assess quality of life and factors affecting it in women ...
Women's Health Initiative estrogen plus progestin clinical trial: A study that does not allow establishing relevant clinical risks
(Lippincott Williams and Wilkins, 2015)
© 2015 by The North American Menopause Society. Objective: This study aims to determine time differences (differences in restricted mean survival times [RMSTs]) in the onset of invasive breast cancer, coronary heart disease, ...